Cel Sci (CVM) Research & Development (2010 - 2026)
Cel Sci (CVM) posted Research & Development of $3.65 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 2.4% from $3.74 million a year earlier and down 3.1% from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Cel Sci was $14.8 million, down 11.2% year-over-year; for FY2025 (ended Sep 30, 2025), it was $15.89 million, down 12.5% from FY2024.
- Annual Research & Development has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
- In prior fiscal years, Cel Sci's Research & Development was $18.16 million in FY2024 (-19.2%), $22.47 million in FY2023 (-11.4%), $25.36 million in FY2022 (+9.7%) and $23.11 million in FY2021 (+29.5%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Research & Development since fiscal Q4 2019.
- On a year-over-year basis, Research & Development has declined in each of the last six quarters, with an average decline of 11.2% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q2 2022, with growth of 24.9%; the weakest was fiscal Q2 2024, with a decline of 23.9%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $3.77 million (Q2 2026), $3.68 million (Q1 2026) and $3.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - | 3.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.65 Mn |
| Mar 31, 2026 | 3.77 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 4.01 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 4.35 Mn |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 5.73 Mn |
| Mar 31, 2023 | 6.08 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 6.46 Mn |
| Jun 30, 2022 | 6.29 Mn |
| Mar 31, 2022 | 6.52 Mn |
| Dec 31, 2021 | 6.08 Mn |
| Sep 30, 2021 | 5.29 Mn |
API Access
Cel Sci Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();